Identification of activated tumor antigen-reactive CD8+ cells in healthy individuals

T V Lee1, B W Anderson, G E Peoples

  • 1Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

Oncology Reports
|April 18, 2000
PubMed

Insights

Tumor-associated lymphocytes (TALs) in healthy individuals can be activated by HER-2 peptide E75, producing interferon-gamma (IFN-γ). This suggests a role for these T cells in natural immunosurveillance against tumors.

Area of Science:

  • Immunology
  • Cancer Research
  • Cellular Biology

Background:

  • Tumor-associated lymphocytes (TALs) play a role in anti-tumor immunity.
  • The HER-2 peptide E75 is an immunodominant CTL epitope found in ovarian and breast cancers.
  • Understanding the activation of CD8+ T cells by tumor antigens is crucial for cancer immunotherapy.

Purpose of the Study:

  • To investigate the ability of the HER-2 peptide E75 to activate effector functions in CD8+ T cells from healthy individuals.
  • To compare the immune response to E75 with responses to other tumor antigens and an influenza peptide.
  • To explore the potential for natural immunosurveillance mediated by tumor antigen-reactive CD8+ T cells.

Main Methods:

  • Freshly isolated CD8+ cells and peripheral blood mononuclear cells (PBMCs) from healthy donors were stimulated with tumor-associated antigen (TAA) peptides, including E75, folate binding protein (FBP), and amino-enhancer of split of Notch (AES).
  • Interferon-gamma (IFN-γ) and Interleukin-2 (IL-2) production by CD8+ cells, and IL-12 production by antigen-presenting cells (APCs) were measured.
  • Responses were compared to those induced by the influenza matrix peptide (M1: 58-66) and assessed for dose-dependency and co-stimulation effects.

Main Results:

  • HER-2 peptide E75 rapidly induced IFN-γ in CD8+ cells from 5 out of 6 healthy donors within 20-24 hours, with detectable levels as early as 6 hours.
  • IFN-γ induction was antigen concentration-dependent and observed with other tumor peptides (FBP, AES) and HLA-A2 matched tumor cells.
  • E75-reactive CD8+ cells induced lower levels of IL-12 and IFN-γ compared to M1 peptide responses, and alphaB7.1 co-stimulation enhanced IL-2 production.

Conclusions:

  • Freshly isolated CD8+ T cells from healthy individuals possess the capacity to respond to tumor-associated antigens like HER-2 peptide E75.
  • The presence of tumor antigen-reactive CD8+ T cells suggests a potential mechanism for natural immunosurveillance.
  • These findings contribute to understanding immune regulation by tumors and may inform the development of cancer immunotherapies.

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...